PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q1 EPS of $0.56, $1.12 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $83.13 million versus the consensus estimate of $80.5 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.